Related Experiment Video
Updated: Nov 21, 2025

07:05
Viability of Bioprinted Cellular Constructs Using a Three Dispenser Cartesian Printer
Published on: September 22, 2015
10.3K
Evolution of Bioinks and Additive Manufacturing Technologies for 3D Bioprinting
Rod R Jose1, Maria J Rodriguez1, Thomas A Dixon1
1Department of Biomedical Engineering, 4 Colby Street, Tufts University, Medford, Massachusetts 02155, United States.
ACS Biomaterials Science & Engineering
|January 14, 2021
Summary
Three-dimensional (3D) printing, an additive manufacturing (AM) technology, revolutionizes biomedical engineering by enabling on-demand fabrication of patient-specific tissues and medical devices. This review explores AM methods for 3D bioprinting, bio-inks, and future challenges.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Additive Manufacturing (AM)
Background:
- Additive Manufacturing (AM), commonly known as 3D printing, represents a significant disruption in traditional manufacturing.
- Its capability to create complex geometries previously unachievable marks a potential industrial revolution.
- Key applications are emerging in biomedical engineering and translational medicine for customized medical devices and tissue scaffolds.
Purpose of the Study:
- To review the evolution and concepts of bio-"inks" and bioprinted devices and tissues over the past two decades.
- To examine various additive manufacturing methods used in 3D bioprinting of cells and scaffolds.
- To analyze the benefits and practical considerations of different AM techniques for bioprinting.
Main Methods:
- Comprehensive review of literature on 3D bioprinting techniques and applications.
- Analysis of different additive manufacturing processes relevant to tissue engineering.
- Discussion of bio-ink formulations and their role in 3D bioprinting.
Main Results:
- Additive Manufacturing (AM) enables on-demand fabrication of patient-specific living tissues and complex medical device geometries.
- Various AM methods have been successfully applied to 3D bioprinting of cells and scaffolds, showing rapid progress.
- The field has seen significant evolution in bio-ink development and bioprinting technologies over the last 20 years.
Conclusions:
- 3D bioprinting holds immense promise for on-demand production of patient-specific tissues, advancing regenerative medicine.
- Continued rapid progress in AM techniques is crucial for overcoming current bottlenecks in the bioprinting industry.
- Future research should focus on addressing limitations to fully realize the potential of 3D bioprinting in clinical applications.

